A double-blind placebo-controlled trial investigating the efficacy of 12 weeks of dienogest 2 mg/day for the treatment of endometriosis-associated pain
article
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This double-blind placebo-controlled trial investigated the efficacy of 12 weeks of dienogest 2 mg/day for treating endometriosis-associated pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (4)
- Dienogest Versus Leuprolide Acetate for Recurrent Pelvic Pain Following Laparoscopic Treatment of Endometriosis 2018
- Outcome of Laproscopic Treatment of Chronic Pelvic Pain with Endometriosis Cases Followed by Post Operative Progestogens 2019
- Endometriose 2015
- Was mit konservativen Maßnahmen zu erzielen ist 2015
Cited by (4)
- Outcome of Laproscopic Treatment of Chronic Pelvic Pain with Endometriosis Cases Followed by Post Operative Progestogens 2019
- Dienogest Versus Leuprolide Acetate for Recurrent Pelvic Pain Following Laparoscopic Treatment of Endometriosis 2018
- Endometriose 2015
- Was mit konservativen Maßnahmen zu erzielen ist 2015
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK